In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...
Sanford CFO Nick Olson explains how the biggest rural healthcare provider in the country views the RHTP funding. In this episode of HL Shorts we hear from Nick Olson, CFo of Sanford Health, on the ...
Hecla Mining Company (NYSE:HL) is among the 15 Best Performing Silver Stocks to Buy. Hecla Mining Company (NYSE:HL) announced on December 1, 2025, that the Polaris Exploration Project in Nevada’s ...
We may receive a commission on purchases made from links. Whether you spend your days laboring on a work site or in a garage, or count yourself among the millions of home improvement DIYers in the ...
We may receive a commission on purchases made from links. If you want to carry an easily concealable high-powered flashlight like those used by agents of the Federal Bureau of Investigation (FBI), ...
A 3D virtual model of the PKMYT1–PROTAC–CRBN ternary complex depicting how Insilico Medicine’s bifunctional proteolysis-targeting chimera (PROTAC) D16-M1P2 (shown in yellow) inhibits ...
Security settings on Windows PCs often have admin rights enabled by default. It makes sense since most normal users shouldn’t need admin rights. However, many standard Windows users will come across ...
Pfizer, Arvinas lose interest in commercializing PROTAC inhibitor, leading to layoffs at the biotech
Having already stripped back their development plans for the estrogen receptor (ER) degrader vepdegestrant on the back of mixed data, Pfizer and Arvinas have now decided to wash their hands of the ...
As an added bonus, ProTac can be set to a "flicker mode" in which the PDLC continuously (and rapidly) switches back and forth between its transparent and opaque states. This allows the system to ...
The end of the undruggable: Targeted protein degradation therapies open new frontiers in cancer care
Targeted protein degradation (TPD) therapy is a promising new class of targeted treatments. Based on a cell’s natural mechanism for eliminating diseased proteins, this therapy can combat hard-to-treat ...
Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results